Work

A phase 2 trial of combination low-dose thalidomide and prednisone for the treatment of myelofibrosis with myeloid metaplasia

Year: 2003

Type: article

Study design: Clinical Trial

Source: Blood

DOI: 10.1182/blood-2002-09-2928

Authors: Ruben A. Mesa, David P. Steensma, Animesh Pardanani, Chin-Yang Li, Michelle Elliott, Scott H. Kaufmann, Gregory Wiseman, Leigh A. Gray, Georgene Schroeder, Terra Reeder, Jerome B. Zeldis, Ayalew Tefferi

Institutions: Mayo Clinic, Celgene (United States)

Language: English

Topic: Myeloproliferative Neoplasms: Diagnosis and Treatment

Subfield: Genetics

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funders: Mayo Clinic, Celgene

OpenAlex ID: W2125469922

FWCI: 7.914

Cites: 48

Cited by: 283

Related to: 10